|
|
 |
Welcome to the online version of Neurosurgery Notes, the practice newsletter for Carolina Neurosurgery & Spine Associates. To find out more about the practice or to subscribe to our newsletter, click the links to the left. To read the articles in this issue, click below.
In This Issue:
Carolina Neurosurgery & Spine Associates Implants The First Lumbar Artificial Disc In The Carolinas
The Charité Artificial Disc is the first device of its kind to be approved by the U.S. Food and Drug Administration (FDA). The artificial disc, which is used to replace a damaged or worn spinal disc, is designed to be an alternative to spinal fusion surgery. full story
Innovative Drug & Delivery Method May Revolutionize Treatment Of Brain Tumors
The Phase III Randomized Evaluation of Convection-Enhanced Delivery of IL13-PE38QQR with Survival Endpoint (PRECISE) Trial is one of the largest and most comprehensive clinical trials conducted to date for recurrent glioblastoma multiforme (GBM). It is also the first time an immunotherapy for brain tumors has reached a late phase trial.full story
Racing Towards A More Promising Future For Cancer Patients
To help garner local support for brain tumor research efforts in this region, the practice established the Brain Tumor Fund of the Carolinas (BTFC). This fund relies on philanthropic contributions to sustain its efforts to provide new technologies,clinical research, and support services for brain tumor patients. full story
Practice Neurosurgeon Elected Vice President Of The Congress Of Neurological Surgeons
Anthony Asher, M.D., of Carolina Neurosurgery & Spine Associates, and Director of the Brain Tumor Programs at both Carolinas Medical Center and Presbyterian Hospital, was elected Vice President of the Congress of Neurological Surgeons (CNS) at the organizations annual meeting held October 16-21 in San Francisco. full story
|
 |